All things tend to regress to the mean.
Scientists seek the holy grail for PTSD research: targets in the brain that could respond to drugs.
Vaccine-preventable diseases cost the U.S. $9 billion in 2015, mostly because unvaccinated people got sick.
Novel treatments for neurological diseases might be possible with a flexible mesh that can prod individual brain cells.
A nonprofit is tapping sequencing technology to guide treatment for thousands of patients.
How the search giant found itself breeding mosquitoes to try to stop the spread of the Zika virus.
Modifying a child’s immune system to fight off leukemia can yield dramatic results, but the treatments are dangerous and no one knows if they’re permanent.
Cattle that can crank out human antibodies are being tested as a first line of defense against infectious diseases.
There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Nobody agrees on how best to collect data about diseases that threaten human health. That looks set to change.